Proton beam radiotherapy for uveal melanoma: Results of Curie Institut-Orsay Proton Therapy Center (ICPO)

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 3, 2006, Pages 780-787

  Dendale, Rémi ^a   Lumbroso Le Rouic, Livia ^a   Noel, Georges ^a   Feuvret, Loïc ^a   Levy, Christine ^a   Delacroix, Sabine ^a   Meyer, Anne ^b   Nauraye, Catherine ^a   Mazal, Alejandro ^a   Mammar, Hamid ^a   Garcia, Paul ^a   D'Hermies, François ^b   Frau, Eric ^c   Plancher, Corine ^a   Asselain, Bernard ^a   Schlienger, Pierre ^a   Mazeron, Jean Jacques ^a   Desjardins, Laurence ^a  

^a INSTITUT CURIE   (France)

^b HÔTEL DIEU   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

Enucleation; Local control; Ocular complication; Proton beam radiotherapy; Survival; Uveal melanoma

Indexed keywords

DISEASES; PATIENT TREATMENT; PROTON BEAMS; RADIOTHERAPY; TUMORS;

ENUCLEATION; LOCAL CONTROL; OCULAR COMPLICATION; PROTON BEAM RADIOTHERAPY; SURVIVAL; UVEAL MELANOMA;

DIAGNOSTIC RADIOGRAPHY;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COBALT THERAPY; DISEASE FREE SURVIVAL; ENUCLEATION; EYE DISEASE; FEMALE; FOLLOW UP; GENDER; HEALTH CENTER; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETINA; RETINA DETACHMENT; RETINA MACULA LUTEA; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; THICKNESS; TREATMENT OUTCOME; TUMOR LOCALIZATION; UVEA MELANOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; EYE ENUCLEATION; FEMALE; HUMANS; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROTONS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 33646905972     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.01.020     Document Type: Article

References (53)

1. Vidal J.L., Bacin F., Albuisson E., et al. ["Melanoma 92". Epidemiological study of uveal melanoma in France]. J Fr Ophtalmol 18 (1995) 520-528
2. Scotto J., Fraumeni J.F.J., and Lee J.A. Melanomas of the eye and other noncutaneous sites. epidemiologic aspects. J Natl Cancer Inst 56 (1976) 489-491
3. Stallard H.B. Partial choroidectomy. Br J Ophthalmol 50 (1966) 660-662
4. Damato B. Adjunctive plaque radiotherapy after local resection of uveal melanoma. Front Radiat Ther Oncol 30 (1997) 123-132
5. Foulds W.S. The local excision of choroidal melanomata. Trans Ophthalmol Soc U K 93 (1973) 343-346
6. Kivela T., Puusaari I., and Damato B. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness. A matched case-control study. Ophthalmology 110 (2003) 2235-2244
7. Lommatzsch P.K. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas. Twenty years' experience. Am J Clin Oncol 10 (1987) 146-151
8. Stallard H.B. Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol 50 (1966) 147-155
9. Dieckmann K., Georg D., Zehetmayer M., et al. LINAC based stereotactic radiotherapy of uveal melanoma. 4 years clinical experience. Radiother Oncol 67 (2003) 199-206
10. Char D.H., Castro J.R., Quivey J.M., et al. Helium ion charged particle therapy for choroidal melanoma. Ophthalmology 87 (1980) 565-570
11. Lumbroso L., Levy C., Plancher C., et al. [Results of proton beam irradiation for treatment of choroidal melanoma]. J Fr Ophtalmol 25 (2002) 290-297
12. Gradoudas E.S., Goitein M., Koehler A., et al. Proton irradiation of choroidal melanomas. Preliminary results. Arch Ophthalmol 96 (1978) 1583-1591
13. Gragoudas E.S., Goitein M., Koehler A.M., et al. Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol 83 (1977) 665-673
14. Egger E., Zografos L., Munkel G., et al. Results of proton radiotherapy for uveal melanomas. Front Radiat Ther Oncol 30 (1997) 111-122
15. Brovkina A.F., and Zarubei G.D. Ciliochoroidal melanomas treated with a narrow medical proton beam. Arch Ophthalmol 104 (1986) 402-404
16. Seddon J.M., Gragoudas E.S., Albert D.M., et al. Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol 99 (1985) 282-290
17. Rosenwald J.C., Bridier A., Sabattier R., et al. [Preliminary dosimetry study of the Orsay synchrocyclotron proton beam with a view to applying it therapeutically]. Ophtalmologie 4 (1990) 123-127
18. Lumbroso L., Levy C., Plancher C., et al. [Results of proton beam irradiation for treatment of choroidal melanoma]. J Fr Ophtalmol 25 (2002) 290-297
19. Desjardins L., Levy C., d'Hermies F., et al. [Initial results of proton therapy in choroidal melanoma at the d'Orsay center for Proton Therapy; The first 464 cases]. Cancer Radiother 1 (1997) 222-226
20. Schlienger P., Habrand J.L., Schwartz L., et al. Initial results with one-year minimum follow-up of the first 146 patients with a uveal melanoma treated with protons at CPO (Orsay). Bull Cancer Radiother 83 (1996) 212s-214s
21. Egger E., Schalenbourg A., Zografos L., et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 51 (2001) 138-147
22. Goitein M., and Miller T. Planning proton therapy of the eye. Med Phys 10 (1983) 275-283
23. Perret C. The therapy planning program EYE (1987), Swiss Institute for Nuclear Research Internal Report;
24. Sheen M. EYEPLAN proton therapy planning program (1995), Claterbridge Centre for Oncology, Bebington, Wirral, UK Internal Report;
25. Kaplan E., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1971) 457-481
26. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
27. Wilson M.W., and Hungerford J.L. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology 106 (1999) 1579-1587
28. Char D.H., Quivey J.M., Castro J.R., et al. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology 100 (1993) 1547-1554
29. Desjardins L., Lumbroso L., Levy C., et al. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy. Indications and comparison of local recurrence rates]. J Fr Ophtalmol 26 (2003) 269-276
30. Fuss M., Loredo L.N., Blacharski P.A., et al. Proton radiation therapy for medium and large choroidal melanoma. Preservation of the eye and its functionality. Int J Radiat Oncol Biol Phys 49 (2001) 1053-1059
31. Munzenrider J.E., Verhey L.J., Gragoudas E.S., et al. Conservative treatment of uveal melanoma. Local recurrence after proton beam therapy. Int J Radiat Oncol Biol Phys 17 (1989) 493-498
32. Char D.H., Kroll S.M., and Castro J. Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol 125 (1998) 81-89
33. Courdi A., Caujolle J.P., Grange J.D., et al. Results of proton therapy of uveal melanomas treated in Nice. Int J Radiat Oncol Biol Phys 45 (1999) 5-11
34. Egan K.M., Ryan L.M., and Gragoudas E.S. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma. An example of regression on time-dependent. Arch Ophthalmol 116 (1998) 366-370
35. Harbour J.W., Char D.H., Kroll S., et al. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma. Ophthalmology 104 (1997) 1785-1792 discussion 1792-1783
36. Prescher G., Bornfeld N., Hirche H., et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347 (1996) 1222-1225
37. Foss A.J., Whelehan I., Hungerford J.L., et al. Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma. Br J Ophthalmol 81 (1997) 748-754
38. Wilson M.W., and Hungerford J.L. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology 106 (1999) 1579-1587
39. Habermalz H.J., and Fischer J.J. Radiation therapy of malignant melanoma. Experience with high individual treatment doses. Cancer 38 (1976) 2258-2262
40. Bentzen S.M., Overgaard J., Thames H.D., et al. Clinical radiobiology of malignant melanoma. Radiother Oncol 16 (1989) 169-182
41. Fowler J.F. Radioresponsiveness of malignant melanoma to fractionated irradiation. Int J Radiat Oncol Biol Phys 10 (1984) 439-440
42. Noel G., Simon J.M., Valery C.A., et al. Linac radiosurgery for brain metastasis of melanoma. Stereotact Funct Neurosurg 79 (2002) 245-255
43. Gragoudas E.S., Lane A.M., Regan S., et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol 118 (2000) 773-778
44. Chauvel P., and Iborra N. Uveal melanoma relapses. The controversy about safety margins (2004), PTCOG, Paris
45. Dendale R., Lumbroso-Le Rouic R., Delacroix S., et al. Transpupillary thermotherapy and protontherapy association for posterior choroidal melanoma (2004), PTCOG, Paris [Abstract]
46. Bourhis J., De Crevoisier R., Abdulkarim B., et al. A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 46 (2000) 1105-1108
47. Antonadou D., Throuvalas N., Petridis A., et al. Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 57 (2003) 402-408
48. Belkacemi Y., Rat P., Piel G., et al. Lens epithelial cell protection by aminothiol WR-1065 and anetholedithiolethione from ionizing radiation. Int J Cancer 96 (2001) 15-26
49. Athanassiou H., Antonadou D., Coliarakis N., et al. Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas. Results of a randomized trial. Int J Radiat Oncol Biol Phys 56 (2003) 1154-1160
50. Reddy V.N., Ikebe H., Giblin F.J., et al. Effect of radioprotective agents on X-ray cataracts. Lens Eye Toxic Res 6 (1989) 573-588
51. Salomon O., Rosenberg N., Steinberg D.M., et al. Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet polymorphism located on the glycoprotein Ibalpha gene. Ophthalmology 111 (2004) 184-188
52. Lumbroso L., Desjardins L., Levy C., et al. Intraocular inflammation after proton beam irradiation for uveal melanoma. Br J Ophthalmol 85 (2001) 1305-1308
53. Char D.H., Bove R., and Phillips T.L. Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments. Trans Am Ophthalmol Soc 101 (2003) 53-56